Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 137 of 144 pages ‹ First < 135 136 137 138 139 > Last ›
HSL17373
Carey J, Barrett A, Weintraub A
Drug Prices: What's Fair?
Business Week 2001 Dec 10
http://www.businessweek.com/magazine/content/01_50/b3761001.htm
HSL2234
Protest against drug company manipulation of doctors' choice of drugs
2001 Dec 8
HSL17375
Brown D, Landy J
Report on PNHP-NY Protest Against Drug Company Manipulation of Doctors’ Choice of Drugs
Physicians for a National Health Program New York Chapter 2001 Dec 8
HSL2232
Japsen B.
Doctors ask to keep prescribing secret AMA data selling reaps $20 million
Chicago Tribune 2001 Dec 4
HSL2233
Steinman M.
New Study Shows Low-Income, Minority Seniors Restrict Use of Prescription Drugs
2001 Dec 4
HSL2230
Morse L.
Scenario: How a resident can spell relief from "ethical heartburn"
AMNews 2001 Dec 3
HSL2231
Greene J.
Medical groups tout AMA drug industry gift campaign
AMNews 2001 Dec 3
HSL3684
US FDA.
Direct-to-you: DTC ads that make sense. [Consumer Talk Paper]
Rockville, Md.: US FDA. 2001 Dec 3
http://www.fda.gov/cder/about/whatwedo/testtube-11.pdf
HSL33
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec; 76:(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271
HSL2241
Quick J.
Maintaining the integrity of the clinical evidence base
World Health Organisation Bulletin 2001 Dec;
HSL2259
Weber LJ, Wayland MT, Holton B.
Health care professionals and industry: reducing conflicts of interest and established best practices.
Arch Phys Med Rehabil 2001 Dec; 82:(12):
http://linkinghub.elsevier.com/retrieve/pii/aapmr082b0s20
HSL2375
Newsweek 'adverzine'?
Consumers Union 2001 Dec; 63
HSL2376
Anonymous .
DTC advertising: Mixed messages
CMJ 2001 Dec; 133:(10):20
HSL5380
Steinman MA, Sands LP, Covinsky KE.
Self-restriction of medications due to cost in seniors without prescription coverage.
J Gen Intern Med 2001 Dec; 16:(12):793-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2001.10412.x
HSL7828
Lima HA.
Reimbursement issues for biotherapies: trends and future issues
ASHP Midyear Clinical Meeting 2001 Dec; 36:
HSL7829
Mangino MH, Ptachcinski RJ, Hrinya M, Stdenis J.
Five year experience with a medication acquisition cost reduction program for the indigent
ASHP Midyear Clinical Meeting 2001 Dec; 36:
HSL7830
Kostek NE.
Effective use of managed care contracting to improve inpatient revenues in an acute care setting
ASHP Midyear Clinical Meeting 2001 Dec; 36:
HSL7832
Haberman DJ, Clifton GD.
Development of an automated service to support access to pharmaceutical companies' patient assistance program
ASHP Midyear Clinical Meeting 2001 Dec; 36:
HSL7833
Shah ND.
Use of trend data on medication use volume in the forecasting process
ASHP Midyear Clinical Meeting 2001 Dec; 36:
HSL10462
Zanamivir: a second look - Still no tangible impact on influenza.
Prescrire Int 2001 Dec; 10:(56):175-7
HSL17991
Meade-D'Alisera P, Merriweather T, Wentland M.
Impact of commercial marketing on patient demand.
Urol Nurs 2001 Dec; 21:(6):406-7,
http://www.ncbi.nlm.nih.gov/pubmed/11998507
HSL2229
Survey Finds DTC Ads Good for Communicating Basic Information
Reuters Health 2001 Nov 29
HSL2228
De Bourbon L.
Poll: Many Don't Fill Prescriptions
AP Business Writer 2001 Nov 28
HSL2226
The Remicade Letters
CBS News 2001 Nov 27
http://www.cbc.ca/disclosure/archives/0111_letters/story.html
HSL2227
Marketing Medication: Can a Good Deal Mean Bad Medicine?
ABC News 2001 Nov 27
http://web.archive.org/web/20040917075843/http://abcnews.go.com/sections/GMA/GoodMorningAmerica/GMA011127Free_prozac.html
HSL20394
Sibbald B
In Russia, medical profession plods toward 21st century
CMAJ 2001 Nov 27; 165:(11):1521
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC81679/
HSL2223
A complaint about drug company advertising
BMJ 2001 Nov 24
HSL2224
Burton R, Burton B
Selling drugs -- with a little help from a journalist
BMJ 2001 Nov 24
HSL2225
Sweet M
Sponsored journalism award shocks Australian media
BMJ 2001 Nov 24
HSL17999
Carvel D
A complaint about drug company advertising.
BMJ 2001 Nov 24; 323:(7323):1259
http://www.bmj.com/cgi/content/citation/323/7323/1259
HSL12934
Ashmore R, Carver N.
Mental health nursing. The pharmaceutical industry and mental health nursing.
British Journal of Nursing 2001 Nov 22; 10:(21):1396-402
http://www.britishjournalofnursing.com/
HSL2218
Reporting of 6 Month vs 12 Month Data in a Clinical Trial of Celecoxib
JAMA 2001 Nov 21
http://jama.ama-assn.org/cgi/content/extract/286/19/2398
HSL2220
Petersen M.
Increased Spending on Drugs Is Linked to More Advertising
New York Times 2001 Nov 21
http://www.nytimes.com/2001/11/21/business/21DRUG.html?pagewanted=1
HSL2221
Silverman E.
Consumers buy what drug firms pitch
Star-Ledger 2001 Nov 21
HSL2222
Bristol-Myers Squibb Effort to Extend Glucophage Patent Galvanizes Congress and Divides Drug Industry
Kaisernetwork.org 2001 Nov 21
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=8166
HSL2260
Wright JM, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
JAMA 2001 Nov 21; 286:(19):2398-400
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11712925&query_hl=7
HSL2509
Wright JL, Perry TL, Bassett KL, Chambers GK.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [2nd of 3 letters]
JAMA 2001 Nov 21; 286:(19):2398-9
http://web.archive.org/web/20021019090659/http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html
HSL2560
Hrachovec J, Mora M.
Reporting of 6-month vs 12-moth data in a clinical trial of celecoxib [1st of 3 letters]
JAMA 2001 Nov 21; 286:(19):2398
http://web.archive.org/web/20100104034241/http://jama.ama-assn.org/
HSL2219
Guerrera F, Jennen B.
Brussels to set record fines for vitamin cartel
Financial times 2001 Nov 20
HSL2214
Wolfe S.
The AMA Does It Again
2001 Nov 19
http://www.citizen.org/publications/release.cfm?ID=7134
HSL2215
Mantz B.
Benefit Plan Accuses Bristol-Myers Of Fraud, Racketeering
Dow Jones Newswires 2001 Nov 19
HSL2216
Pinker S.
Medicine's intellectual property rights attacked in Osler lecture
eCMAJ 2001 Nov 19
www.cmaj.ca/cgi/content/full/166/2/230
HSL2217
Lieberman T.
Drug Discounts Offered to Foster Brand Loyalty
Los Angeles Times 2001 Nov 19
http://articles.latimes.com/2001/nov/19/health/he-5905
HSL2213
Seniors Go North For Cheaper Medication
Yahoo News 2001 Nov 16
HSL2210
McNeil D.
Tuberculosis Group Tries to Spur Research for New Antibiotics
New York Times 2001 Nov 15
http://www.nytimes.com/2001/11/15/international/15DRUG.html?pagewanted=1
HSL2211
Richwine L.
Pediatric Drug-Test Incentives Clear House
Reuters 2001 Nov 15
HSL2212
Davenport J.
Brand names carry price: Quebecers paid $18.7 million too much for drugs - generic manufacturers
Montreal Gazette 2001 Nov 15
HSL2209
Green Light to Put Public Health First at WTO Ministerial Conference in Doha
2001 Nov 14
HSL2208
Boseley S.
Tobacco giant buys rights to lung cancer drugs
The Age 2001 Nov 13
http://www.guardian.co.uk/society/2001/nov/12/cancercare
HSL17997
Postmarketing drug surveillance: what it would take to make it work
CMAJ 2001 Nov 13; 165:(10):1293-1293
http://www.ncbi.nlm.nih.gov/pubmed/11760966
HSL2207
Agovino T.
Bristol-Myers Aims to Secure Monopoly
AP Business Writer 2001 Nov 12
HSL2206
Spurgeon D.
Report clears researcher who broke drug company agreement
BMJ 2001 Nov 10
HSL2205
Cassels A.
The new drug pushers
Montreal Gazette 2001 Nov 9
HSL2204
Lerner S.
The Bayer Boondoggle
Village Voice 2001 Nov 7
http://www.villagevoice.com/2001-11-06/news/the-bayer-boondoggle/1
HSL137
Byron E.
The Web @ Work / Astra Zeneca: A Weekly Case Study
The Wall Street Journal 2001 Nov 5
HSL2203
Wayne L, Petersen M.
A Muscular Lobby Tries to Shape Nation's Bioterror Plan
New York Times 2001 Nov 4
http://www.nytimes.com/2001/11/04/business/04PHAR.html?pagewanted=1
HSL2513
Silverstein F, Simon L, Faich G.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [3rd of 3 letters]
JAMA 2001 Nov 01; 286:(19):2399-2400
http://web.archive.org/web/20021019090659/http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html
HSL7818
Chisholm MA, Garrett CJ.
Increasing transplant patients' access to medications: Medicare and beyond.
Am J Health Syst Pharm 2001 Nov 1; 58:(21):2081-4
http://www.ajhp.org/cgi/reprint/58/21/2081
HSL2261
Meek C .
Direct-to-consumer advertising of prescription medicines: A review of international policy and evidence
Royal Pharmaceutical Society of Great Britain 2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL2264
Brodie M.
Understanding the effects of direct-to-consumer prescription drug advertising
: Henry J. Kaiser Family Foundation 2001 Nov
HSL2553
Meek C.
2001 Nov;
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL7814
Sullivan DL.
Evaluating information in consumer advertisements of prescription drugs.
Ann Pharmacother 2001 Nov; 35:(11):1494
http://www.theannals.com/cgi/reprint/35/11/1494-a
HSL16800
Rosack J
Controversy Erupts Over Ads for ADHD Drugs
Psychiatric News 2001 11 02; 36:(21):20
http://pn.psychiatryonline.org/cgi/content/full/36/21/20
HSL17995
Carney SL, Nair KR, Sales MA, Walsh J.
Pharmaceutical industry-sponsored meetings: good value or just a free meal?
Intern Med J 2001 Nov; 31:(8):488-91
http://www3.interscience.wiley.com/journal/120715721/abstract?CRETRY=1&SRETRY=0
HSL17996
Komesaroff P.
Doctors' interactions with the pharmaceutical industry: science or commerce?
Intern Med J 2001 Nov; 31:(8):446-7
http://www3.interscience.wiley.com/journal/120715732/abstract
HSL17998
Hoffman JR
Annals supplement on the American Heart Association proceedings
Ann Emerg Med 2001 Nov; 38:(5):605
http://www.ncbi.nlm.nih.gov/pubmed/11679880
HSL2032
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30; 165:(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226
HSL17374
Thompson J, Baird P, Downie J
Report of the Committee of Inquiry on the Case Involving Dr Nancy Oliveri, the Hospital for Sick Children, the University of Toronto, and Apotex Inc
2001 Oct 26
www.law.ualberta.ca/centres/hli/userfiles/10_2moelorifrm.pdf
HSL2146
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31; 286:(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994
HSL16742
Wolfe S, Lurie P.
On the Anthrax Front: Fear and Vigilance
The New York Times 2001 Oct 24
HSL2198
Watson R.
Consumer groups fight plans for "direct to patient" drug advertisements
BMJ 2001 Oct 20
HSL18000
Ram FS, Wright J, Brocklebank D, White JE.
Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.
BMJ 2001 Oct 20; 323:(7318):901-5
http://www.bmj.com/cgi/content/full/323/7318/901?view=long&pmid=11668134
HSL5309
Attaran A, Gillespie-White L.
Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
JAMA 2001 Oct 17; 286:(15):1886-92
http://jama.ama-assn.org/cgi/content/full/286/15/1886
HSL2197
Sanders's 'Reasonable drug pricing' amendment
BNA Daily Report for Executives 2001 Oct 15
HSL2195
Norton A.
Magazine Drug Ads Deemed Too Vague
Reuters Health 2001 Oct 5
HSL2196
News of Prescrire's Reps Monitoring Network: Pretences and off-label claims
Prescrire 2001 Oct 01
http://www.ncbi.nlm.nih.gov/pubmed/11824429
HSL2374
Telles Filho PC, Galdeano LE, Miasso AI, Caliri MH, Mendes IA.
[Drug administration and information dissemination via online]
Rev Bras Enferm 2001 Oct-Dec 01; 54:(4):539-47
HSL4816
Gupta AS.
Research on hire.
Issues Med Ethics 2001 Oct-Dec; 9:(4):111-3
HSL1849
Eliasson G, Hakansson J.
[Keep medical education independent! It should not be a scene of drug industry marketing]
Lakartidningen. 2001 Sep 26; 98:(39):4168-9
HSL4577
Elliott C.
Pharma buys a conscience.
Am Prospect 2001 Sep-Oct 24; 12:(17):16-20
HSL5565
FDA
NDA 21-042 Vioxx (rofecoxib) tablets MACMIS ID # 9456 WARNING LETTER
: FDA 2001 Sep 21
HSL2193
Silversides A.
Ottawa assailed for reinterpreting ad law
The Globe and Mail 2001 Sep 18
HSL2194
Silversides A.
Looser ad rules a headache for drug plans
The Globe and Mail 2001 Sep 18
HSL6975
Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS; International Committee of Medical Journal Editors.
Sponsorship, authorship and accountability.
CMAJ 2001 Sep 18; 165:(6):786-8
HSL2160
Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS.
Sponsorship, authorship, and accountability.
Lancet 2001 Sep 15; 358:(9285):854-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060354
HSL2191
Dyer O.
University accused of violating academic freedom to safeguard funding from drug companies
BMJ 2001 Sep 15
HSL13371
Eliasson M, Bergqvist D.
[Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry].
Lakartidningen 2001 Sep 12; 98:(37):3913-6
http://www.ncbi.nlm.nih.gov/pubmed/11586830
HSL17372
Major LE
Scientists' independence in drug trials questioned: Medical journal editors want more information about the role of pharmaceutical companies in drug trials.
The Guardian 2001 Sep 10
http://www.guardian.co.uk/education/2001/sep/10/research.highereducation
HSL19525
An Unhealthy Influence on Doctors
The New York Times 2001 Sep 10
http://www.nytimes.com/2001/09/10/opinion/an-unhealthy-influence-on-doctors.html
HSL2266
McCarthy M.
Drug firm support of American Medical Association ethics effort draws fire.
Lancet 2001 Sep 8; 358:(9284):821
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060214
HSL2190
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical Branding of Resident Physicians
JAMA 2001 09 05286:(9):1024-5
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a
HSL2334
Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS.
Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
Ann Clin Psychiatry 2001 Sep; 13:(3):159-62
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11791954&query_hl=53
HSL7409
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS
Graphics in Pharmaceutical Advertisements: Are They Truthful, Are They Adequately Detailed?
Los Angeles: UCLA School of Medicine 2001 Sep
http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful
HSL7767
Antonopoulos J.
Crossing the border: seniors turn to Canada and Mexico to fight high prescription costs
Acta Poloniae Pharmaceutica Drug Research 2001 Sep-Oct; 4:4-7
HSL7811
Scheindlin S.
Acacia-remarkable excipient: past, present, and future of gum arabic
Journal of the American Pharmaceutical Association 2001 Sep-Oct; 41:669-671
HSL18001
Reidenberg MM.
An open invitation for an explanation about how drug prices are set.
Clin Pharmacol Ther 2001 Sep; 70:(3):205-7
http://www.nature.com/clpt/journal/v70/n3/abs/clpt200183a.html
HSL20380
Rakow T
Differences in belief about likely outcomes account for differences in doctors' treatment preferences: but what accounts for the differences in belief?
Qual Health Care. 2001 Sep; 10:i44–i49.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1765736/
HSL2189
Okie S.
AMA Blasted for Letting Drug Firms Pay for Ethics Campaign
Washington Post 2001 Aug 30
HSL2186
AMA Discourages Drug Co. Gifts
New York Times 2001 Aug 29
HSL2187
Guyatt G.
Don't allow drug firms to intimidate
Straightgoods 2001 Aug 29
Page 137 of 144 pages ‹ First < 135 136 137 138 139 > Last ›
